Last reviewed · How we verify

ON 01910.Na and irinotecan

Traws Pharma, Inc. · Phase 1 active Small molecule

ON 01910.Na and irinotecan is a Small molecule drug developed by Traws Pharma, Inc.. It is currently in Phase 1 development. Also known as: Campostar, camptothecin-11, irinotecan, irinotecan HCl.

At a glance

Generic nameON 01910.Na and irinotecan
Also known asCampostar, camptothecin-11, irinotecan, irinotecan HCl, CPT-11
SponsorTraws Pharma, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ON 01910.Na and irinotecan

What is ON 01910.Na and irinotecan?

ON 01910.Na and irinotecan is a Small molecule drug developed by Traws Pharma, Inc..

Who makes ON 01910.Na and irinotecan?

ON 01910.Na and irinotecan is developed by Traws Pharma, Inc. (see full Traws Pharma, Inc. pipeline at /company/traws-pharma-inc).

Is ON 01910.Na and irinotecan also known as anything else?

ON 01910.Na and irinotecan is also known as Campostar, camptothecin-11, irinotecan, irinotecan HCl, CPT-11.

What development phase is ON 01910.Na and irinotecan in?

ON 01910.Na and irinotecan is in Phase 1.

Related